MG
PBYI icon

Michael Gelband’s Puma Biotechnology PBYI Stock Holding History

Michael Gelband’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,905
Closed -$79K – 1919
2024
Q3 		$79K Buy
+30,905
New +$93.5K ﹤0.01% 1523
2024
Q2 		– Sell
-15,627
Closed -$83K – 1867
2024
Q1 		$83K Sell
15,627
-37,613
-71% -$203K ﹤0.01% 1424
2023
Q4 		$231K Buy
+53,240
New +$176K ﹤0.01% 1245
2022
Q2 		– Sell
-10,077
Closed -$29K – 2319
2022
Q1 		$29K Sell
10,077
-93,878
-90% -$243K ﹤0.01% 2095
2021
Q4 		$316K Sell
103,955
-10,562
-9% -$45.8K ﹤0.01% 1640
2021
Q3 		$803K Buy
114,517
+74,186
+184% +$555K 0.01% 1129
2021
Q2 		$370K Sell
40,331
-18,619
-32% -$189K ﹤0.01% 1607
2021
Q1 		$573K Buy
58,950
+28,449
+93% +$318K 0.01% 1249
2020
Q4 		$313K Sell
30,501
-7,641
-20% -$77.4K ﹤0.01% 1524
2020
Q3 		$385K Buy
38,142
+5,885
+18% +$59.9K 0.01% 1159
2020
Q2 		$336K Buy
+32,257
New +$334K 0.01% 1261
2019
Q4 		– Sell
-33,057
Closed -$356K – 1801
2019
Q3 		$356K Buy
+33,057
New +$357K 0.01% 809

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's PBYI Position: Q4 2024 in Review

Michael Gelband sold out of Puma Biotechnology (PBYI) in Q4 2024, closing a stake of 30,905 shares — an estimated $79K sold.

Michael Gelband first reported a position in PBYI in Q3 2019 and held it in 12 quarters. The position peaked at $803K in Q3 2021. 112 funds tracked by Wall St. Rank hold PBYI as of Q4 2024.

  • Michael Gelband reported no remaining Puma Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Michael Gelband sold 30,905 Puma Biotechnology shares in Q4 2024, an estimated $79K.
  • Michael Gelband first reported a position in Puma Biotechnology in Q3 2019 and held it in 12 quarters.
  • Michael Gelband's Puma Biotechnology position peaked at $803K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.